Author

G. R. Cutter

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Approach:machine learning (classical)· 1 Organism:mouse· 1

Frequent Co-Authors

J. F. Modiano· 2 shared L. J. Mills· 2 shared A. Borgatti· 1 shared A. Chehadeh· 1 shared A. J. Donnelly· 1 shared A. Khammanivong· 1 shared A. L. Sarver· 1 shared A. Montoya· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. F. Modiano

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma.

K. M. Makielski, A. L. Sarver, M. S. Henson, K. M. Stuebner, A. Borgatti, L. Suksanpaisan, C. Preusser, A.-F. Tabaran, I. Cornax, M. G. O'Sullivan, A. Chehadeh, D. Groschen, K. Bergsrud, S. Pracht, A. Winter, , S. Naik

This study evaluates neoadjuvant oncolytic virus therapy in dogs with osteosarcoma, finding it safe and associated with increased long-term survivorship and immune gene expression.

bioRxiv · Apr 16, 2023Cancer Biology

Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning

K. Makielski, A. J. Donnelly, A. Khammanivong, M. C. Scott, A. R. Ortiz, D. C. Galvan, H. Tomiyasu, C. Amaya, K. Ward, A. Montoya, J. R. Garbe, L. J. Mills, G. R. Cutter, J. M. Fenger, W. C. Kisseberth, , J. F. Modiano

The paper develops a gene signature using exosomal RNA from canine osteosarcoma xenografts and machine learning to detect residual disease in dogs, showing improved remission outcomes in validation samples.

bioRxiv · Feb 11, 2021Cancer Biology